Effect Of Multiple Biofortified Food Crops On Micronutrient Status And Immune Function Among Indian Infants and Their Mothers

NCT ID: NCT02648893

Last Updated: 2023-05-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-28

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, meals based on multiple food crops (containing either biofortified or commercially-available food crops) will be fed to young children in Madanapalle, Andhra Pradesh, India over a period of nine months to measure growth, cognitive changes, and immune function in comparison to children receiving non-biofortified crops. Mothers of the participating children will also be included in the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Iron, zinc, and vitamin A deficiency remain a major worldwide public health problem especially in developing countries such as India. In this randomized study, 200 children aged 6-12 months (and their lactating mothers) from Madanapalle, Andhra Pradesh, India will be fed meals based on (either biofortified or commercially-available) multiple food crops three times per day, six days per week, for nine months. We will recruit children from 6 - 24 months of age. The goal of this study is to examine the effects of the biofortified multiple food crops on immune function, growth, and cognitive function in this age group. The key outcome measures are biomarkers of vitamin A, iron and zinc status, growth (anthropometric z-scores), and immune and cognitive function. Nutrient biomarkers will be assessed at enrollment (baseline), at an intermediate time point (midline; random serial sampling) and after 9 months of follow-up (endline). Additionally, we will measure concentrations of C-reactive protein (CRP) and alpha 1-acid glycoprotein (AGP), as iron and zinc biomarkers can be influenced by inflammation. To assess cognitive function, multiple specific aspects of memory and attention will be assessed. Higher-level, integrative cognitive abilities that require the coordination of multiple specific functions, such as problem-solving and exploratory behavior and global aspects of attention during free play with toys, will also be assessed. In addition, the Development Assessment Scales for Indian Infants (DASII) test will be conducted at baseline, intermediate, and endline assessments to obtain a broad measure of attainment of developmental milestones that can be used to compare the characteristics of this cohort with those reported in the literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin A Deficiency Iron Deficiency Zinc Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MBFC-Exp

The MBFC-Exp (Multiple biofortified food crops - Experimental) arm will consume meals based on biofortified food crops.

Group Type EXPERIMENTAL

Multiple biofortified food crops (MBFC-Exp)

Intervention Type OTHER

Meals from three biofortified food crops will be consumed by children (and potentially their lactating mothers) three times per day, six days per week, for 9 months.

MBFC-C

The MBFC-C (Multiple biofortified food crops - Control) arm will consume the same meals based on non-biofortified (commercially available) food crops.

Group Type ACTIVE_COMPARATOR

Commercially available non-fortified food crops (MBFC-C)

Intervention Type OTHER

This arm will consume meals based on three commercially available (non-biofortified) food crops three times per day, six days per week, for 9 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multiple biofortified food crops (MBFC-Exp)

Meals from three biofortified food crops will be consumed by children (and potentially their lactating mothers) three times per day, six days per week, for 9 months.

Intervention Type OTHER

Commercially available non-fortified food crops (MBFC-C)

This arm will consume meals based on three commercially available (non-biofortified) food crops three times per day, six days per week, for 9 months.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Biofortified food crops Non-biofortified food crops

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children: Age 6 to 24 months (at enrollment);

Mothers: Biological mothers of included children.

Exclusion Criteria

Children

* Age below 6 months or above 24 months (at time of screening);
* Hemoglobin \<9 g/dL (at time of screening);
* Presence of severe malnutrition according to Wellcome Classification (marasmus, marasmic kwashiorkor, kwashiorkor, weight-for-height z-score \< -3);
* Prior known or current diagnoses of HIV/AIDS, Malaria, Dengue fever, Tuberculosis;
* Children whose biological mother is unable to bring her/him to feeding center daily;
* Possibility of migrating out of the study catchment area for more than 4 consecutive weeks;
* Prior or current consumption of iron, zinc, and/or vitamin A supplements;
* Any known dietary allergies.

Mothers

\- Severe anemia (Hemoglobin \<7g/ dL)
Minimum Eligible Age

6 Months

Maximum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SNDT Women's University

OTHER

Sponsor Role collaborator

Arogyavaram Medical Centre

OTHER

Sponsor Role collaborator

Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saurabh Mehta, MBBS, ScD

Role: PRINCIPAL_INVESTIGATOR

Cornell University

Julia L. Finkelstein, ScD

Role: PRINCIPAL_INVESTIGATOR

Cornell University

Shobha Udipi, PhD

Role: PRINCIPAL_INVESTIGATOR

SNDT Women's University

Bonam Wesley, MBBS

Role: PRINCIPAL_INVESTIGATOR

Arogyavaram Medical Centre

Jere D Haas, PhD

Role: PRINCIPAL_INVESTIGATOR

Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arogyavaram Medical Centre

Madanapalle, , India

Site Status

S.N.D.T. Women's University

Mumbai, , India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB #: 1508005782

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trial of Pre-Pregnancy Supplements
NCT01183572 COMPLETED NA